Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter's Syndrome. | Cancers (Basel) | 2022 | 36551520 | PubTator, text mining | PubMed |
| Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next? | Cancers (Basel) | 2022 | 36551511 | PubTator, text mining | PubMed |
| Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential. | Cancers (Basel) | 2022 | 36497266 | PubTator, text mining | PubMed |
| Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study. | Front Oncol | 2022 | 36479077 | PubTator, text mining | PubMed |
| Dysregulation of FBW7 in malignant lymphoproliferative disorders. | Front Oncol | 2022 | 36457505 | PubTator, text mining | PubMed |
Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors. | BMC Cancer | 2022 | 36434612 | PubTator, text mining | PubMed |
| Plasticity in Classical Hodgkin Composite Lymphomas: A Systematic Review. | Cancers (Basel) | 2022 | 36428786 | PubTator, text mining | PubMed |
| CD160 receptor in CLL: Current state and future avenues. | Front Immunol | 2022 | 36420268 | PubTator, text mining | PubMed |
| Activation induced cytidine deaminase: An old friend with new faces. | Front Immunol | 2022 | 36405752 | PubTator, text mining | PubMed |
| Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results. | Hemasphere | 2022 | 36398134 | PubTator, text mining | PubMed |
| Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer. | PLoS Pathog | 2022 | 36395347 | PubTator, text mining | PubMed |
| Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA. | PLoS Pathog | 2022 | 36383559 | PubTator, text mining | PubMed |
| B cells in human lymphoid structures. | Clin Exp Immunol | 2022 | 36370126 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia. | Life (Basel) | 2022 | 36362925 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Diffuse Large B Cell Lymphoma: Characterization and Diagnostic Potential. | Int J Mol Sci | 2022 | 36362114 | PubTator, text mining | PubMed |
| Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma. | Cells | 2022 | 36359790 | PubTator, text mining | PubMed |
| Rheumatoid factor IgM autoantibodies control IgG homeostasis. | Front Immunol | 2022 | 36341420 | PubTator, text mining | PubMed |
| Wells' syndrome possibly caused by hematologic malignancy, influenza vaccination or ibrutinib: A case report. | World J Clin Cases | 2022 | 36338211 | PubTator, text mining | PubMed |
| miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study. | Front Immunol | 2022 | 36325355 | PubTator, text mining | PubMed |
| [Mutational features of immunoglobulin heavy chain variable region gene in patients with chronic lymphocytic leukemia]. | Zhonghua Bing Li Xue Za Zhi | 2022 | 36323543 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=25